Register Login
Register to leave comments
  • News bot May 7, 2026, 8:59 p.m.

    📋 GEOVAX LABS, INC. (GOVX) - Clinical Trial Update

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:27:44

    Event Type: Clinical Trial Update

    Event Details:

    GEOVAX LABS, INC. (GOVX) Announces Clinical Trial Update GEOVAX LABS, INC. (GOVX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: exercise
    • Collaboration: the “Approval Date
      • targeting mpox and smallpox. The program is advancing under an expedited regulatory pathway, with plans to initiate a pivotal Phase 3 clinical trial in the second half of 2026

    🔬 Clinical Development Pipeline (GEOVAX LABS, INC.):

    Product Type Development Stage Therapeutic Area Source
    MVA/HIV62B Vaccine Other Phase PHASE1 HIV Infections ClinicalTrials.gov
    Protein Placebo Other Phase PHASE1 HIV Infections ClinicalTrials.gov
    IHV01 Protein Other Phase PHASE1 HIV Infections ClinicalTrials.gov
    B63521^11 gp120 Other Phase PHASE1 HIV Infections ClinicalTrials.gov
    GEO-D02 DNA Other Phase PHASE1 HIV Infections ClinicalTrials.gov
    JS7 plasmid DNA and MVA62B vaccine Other Phase PHASE1 HIV-1 Infection ClinicalTrials.gov
    Placebo for MVA62B: Other Phase PHASE1 HIV Infections ClinicalTrials.gov
    Placebo for GEO-D03 DNA Other Phase PHASE1 HIV Infections ClinicalTrials.gov
    MVA/HIV62B (MVA62B) vaccine Other Phase PHASE1 HIV Infections ClinicalTrials.gov
    GEO-D03 DNA vaccine Other Phase PHASE1 HIV Infections ClinicalTrials.gov
    Fludarabine Phosphate Other Phase PHASE1 Recurrent Head and Neck Cancer ClinicalTrials.gov
    Ad/PNP Other Phase PHASE1 Recurrent Head and Neck Cancer ClinicalTrials.gov
    Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 Other Phase PHASE1 COVID-19 Infection ClinicalTrials.gov
    Placebo Administration Other Phase PHASE1 COVID-19 Infection ClinicalTrials.gov
    Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1 Other Phase PHASE2 COVID-19 Infection ClinicalTrials.gov
    Diagnostic Laboratory Biomarker Analysis Other Phase PHASE2 COVID-19 Infection ClinicalTrials.gov
    COVID-19 Vaccine Other Phase PHASE2 COVID-19 Infection ClinicalTrials.gov
    Combination Intervention Other Phase PHASE1 HIV/AIDS ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: GEOVAX LABS, INC.
    • Ticker Symbol: GOVX

Search

News categories